Skip to main content
Premium Trial:

Request an Annual Quote

Symyx Partners with Simulations Plus on ADMET Database

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Drug research software maker Simulations Plus will use Symyx's Metabolite database to develop and improve a predictive modeling system for in silico metabolic properties, Symyx said today.

Simulations Plus plans to develop a new module used for predictive modeling of ADMET (absorption, distribution, metabolism, excretion, and toxicity) applications.

The new system will be incorporated into a new Symyx Metabolite module, which will be offered as part of the Simulations Plus ADMET Predictor software later this year.

The Simulations Plus software is used by drug research organizations to improve compound design, lower the cost of experiments, and reduce the number of late product failures.

The Symyx Metabolite software covers xenobiotic transformations and metabolic schemes from publications, and non-proprietary studies from new drug applications published by the Food and Drug Administration.

"One of our explicit aims is the development of a predictive mathematical model that will be capable of identifying specific sites of metabolism," Simulations Plus CEO and Chairman Walt Woltosz said in a statement.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.